Entity Common Stock, Shares Outstanding of Denali Therapeutics Inc. from 04 May 2018 to 20 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Denali Therapeutics Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 04 May 2018 to 20 Feb 2026.
  • Denali Therapeutics Inc. Entity Common Stock, Shares Outstanding for the quarter ending 20 Feb 2026 was 158,591,491, a 9.2% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Denali Therapeutics Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 158,591,491 +13,315,192 +9.2% 20 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 146,661,833 +2,740,209 +1.9% 31 Oct 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 146,212,278 +3,047,014 +2.1% 05 Aug 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 145,276,299 +2,667,263 +1.9% 30 Apr 2025 10-Q 06 May 2025 2025 Q1
Q3 2024 143,921,624 +5,724,776 +4.1% 30 Oct 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 143,165,264 +5,743,133 +4.2% 25 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 142,609,036 +5,720,124 +4.2% 30 Apr 2024 10-Q 07 May 2024 2024 Q1
Q3 2023 138,196,848 +2,383,180 +1.8% 30 Oct 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 137,422,131 +14,073,963 +11% 31 Jul 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 136,888,912 +13,940,532 +11% 01 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 135,813,668 +13,688,087 +11% 27 Oct 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 123,348,168 +1,708,099 +1.4% 01 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 122,948,380 +1,756,170 +1.4% 28 Apr 2022 10-Q 05 May 2022 2022 Q1
Q3 2021 122,125,581 +2,207,085 +1.8% 29 Oct 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 121,640,069 +15,656,944 +15% 28 Jul 2021 10-Q 04 Aug 2021 2021 Q2
Q1 2021 121,192,210 +15,564,028 +15% 26 Apr 2021 10-Q 05 May 2021 2021 Q1
Q3 2020 119,918,496 +23,887,273 +25% 28 Oct 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 105,983,125 +10,141,510 +11% 03 Aug 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 105,628,182 +10,339,135 +11% 29 Apr 2020 10-Q 07 May 2020 2020 Q1
Q3 2019 96,031,223 +1,074,131 +1.1% 30 Oct 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 95,841,615 +1,034,504 +1.1% 31 Jul 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 95,289,047 +847,155 +0.9% 05 Mar 2019 10-K 12 Mar 2019 2018 FY
Q3 2018 94,957,092 02 Nov 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 94,807,111 02 Aug 2018 10-Q 09 Aug 2018 2018 Q2
Q1 2018 94,441,892 04 May 2018 10-Q 11 May 2018 2018 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.